Brain Cancer clinical trials in Florida

59 actively recruiting brain cancer trials at 21 sites across Florida.

Data from ClinicalTrials.gov · last refreshed 2026-07-07

Payments from drug makers to the doctors running these trials

For 2 of the trials on this page, the pharmaceutical company funding the trial also disclosed payments to the physicians leading it — public data from the federal CMS Open Payments database. Paying clinical-trial investigators for site work is expected and necessary for industry-funded trials; the scale and source are simply useful context when you're deciding whether to enroll.

Payments from the drug maker running this trial to its lead doctors

CMS Open Payments · 2024

Baptist Health South Florida funds and runs this clinical trial (NCT04689048). In 2024, Baptist Health South Florida reported paying the doctors leading the trial a total of $65,964 for research work on this study.

Who paid

Blue Earth Diagnostics Limited $65,964

Paid for research work on this trial

RUPESH KOTECHA(oncologist on CancerDrs) $65,964

Questions a patient might reasonably ask

Who is funding this trial, and how does the funding company stand to benefit if the trial succeeds?
Does my oncologist have a financial relationship with the trial sponsor outside of this trial?
Are there non-industry-sponsored trials (NIH, cooperative group) for my condition I should consider?
What are the alternative standards of care I should compare against enrolling here?

Research payments are not, by themselves, a conflict — paying for legitimate trial work is how drug development gets funded. The purpose of Sunshine Act disclosure is to give patients the context, not to make the decision for them.

Source: CMS Open Payments · ClinicalTrials.gov · Dispute process · How we compute this

As displayed on 2026-04-21. Corrections flow from the manufacturer through CMS and are adopted on our next refresh.

Payments from the drug maker running this trial to its lead doctors

CMS Open Payments · 2024

Baptist Health South Florida funds and runs this clinical trial (NCT06048094). In 2024, Baptist Health South Florida reported paying the doctors leading the trial a total of $34,608 for research work on this study.

Who paid

Blue Earth Diagnostics Limited $34,608

Paid for research work on this trial

RUPESH KOTECHA(oncologist on CancerDrs) $34,608

Questions a patient might reasonably ask

Who is funding this trial, and how does the funding company stand to benefit if the trial succeeds?
Does my oncologist have a financial relationship with the trial sponsor outside of this trial?
Are there non-industry-sponsored trials (NIH, cooperative group) for my condition I should consider?
What are the alternative standards of care I should compare against enrolling here?

Source: CMS Open Payments · ClinicalTrials.gov · Dispute process · How we compute this

As displayed on 2026-04-21. Corrections flow from the manufacturer through CMS and are adopted on our next refresh.

Phase 3 Recruiting Academic/Other

Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability

This phase III trial compares the effect of stereotactic radiosurgery to standard of care memantine and whole brain radiation therapy that avoids the hippocampus (the memory zone of the brain) for the treatment of small cell lung cancer th…

Sponsor: NRG Oncology

NCT ID: NCT04804644

Sites in Florida:

UM Sylvester Comprehensive Cancer Center at Coral Gables — Coral Gables, Florida
UM Sylvester Comprehensive Cancer Center at Deerfield Beach — Deerfield Beach, Florida
UF Health Cancer Institute - Gainesville — Gainesville, Florida
University of Miami Miller School of Medicine-Sylvester Cancer Center — Miami, Florida
Moffitt Cancer Center-International Plaza — Tampa, Florida